PRESS RELEASE published on 04/04/2023 at 14:45, 3 years ago The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate
PRESS RELEASE published on 03/23/2023 at 21:30, 3 years ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference
PRESS RELEASE published on 03/16/2023 at 21:10, 3 years ago Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting
PRESS RELEASE published on 03/15/2023 at 13:10, 3 years ago Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study
PRESS RELEASE published on 02/10/2023 at 15:00, 3 years 1 month ago Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
PRESS RELEASE published on 02/01/2023 at 14:15, 3 years 2 months ago Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
PRESS RELEASE published on 01/17/2023 at 14:30, 3 years 2 months ago Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug
Published on 04/08/2026 at 00:10, 30 minutes ago Trans Canada Gold Completes the Acquisition of the Harrison Lake District Scale Gold Property and First Tranche of the Non-Brokered Private Placement
Published on 04/08/2026 at 00:00, 40 minutes ago Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
Published on 04/07/2026 at 22:30, 2 hours 10 minutes ago Kalo Gold Enters into Investor Relations and Marketing Services Agreements
Published on 04/07/2026 at 15:00, 9 hours 40 minutes ago Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Published on 04/07/2026 at 14:45, 9 hours 55 minutes ago Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Published on 04/07/2026 at 16:32, 8 hours 8 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 8 hours 10 minutes ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 15:00, 9 hours 40 minutes ago Amrize Announces Date for First Quarter 2026 Financial Results
Published on 04/07/2026 at 14:55, 9 hours 44 minutes ago Original-Research: Delticom AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 04/07/2026 at 17:57, 6 hours 42 minutes ago Peugeot Invest publishes its 2025 Universal Registration Document
Published on 04/07/2026 at 17:45, 6 hours 55 minutes ago ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Published on 04/07/2026 at 17:38, 7 hours 1 minute ago Reporting on share buyback transactions carried out between March 30 and April 2, 2026
Published on 04/07/2026 at 17:35, 7 hours 5 minutes ago Disclosure of the number of shares and the total number of voting rights as of March 31, 2026
